The Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer’s Act (PL 115-406) amends the Public Health Service Act to bring attention to Alzheimer’s disease and other diseases involving cognitive decline. The bill addresses these diseases through a number of strategies, including:
Issuing grants and awards to establish Alzheimer’s disease and related dementias public health centers of excellence to disseminate current information regarding these diseases to public health officials, health care professionals, and the public, and promote translating promising research into evidence-based therapeutic interventions;
Maintaining and disseminating up-to-date data on the incidence and prevalence of Alzheimer’s disease and related dementias through various sources within the Centers for Disease Control and Prevention; and
Promoting state public health programs focused on Alzheimer’s disease and related dementias to educate and inform the public, improve early detection and diagnosis, curb avoidable hospitalizations, and bolster support of patients and their caregivers.
University of California – A shared biological mechanism may drive the progression of both Alzheimer’s disease and chronic traumatic encephalopathy, a neurodegenerative condition associated with repeated concussions and brain trauma.
STAT – The defective proteins that are widely thought to kill brain neurons and cause, or at least indicate, Alzheimer’s disease do not always have that calamitous result, raising more doubts about conventional approaches to diagnosing and finding treatments for Alzheimer’s.
GenomeWeb - The National Institutes of Health has committed $6 million in fiscal 2017 to fund research into the effects of Alzheimer's disease-associated genetic variants on neural cell biology, in order to improve the overall understanding of the molecular causes of the disease.